<DOC>
	<DOCNO>NCT02654418</DOCNO>
	<brief_summary>SIC 8000 indicated use gastrointestinal endoscopic procedure submucosal lift polyp , adenomas , early-stage cancer gastrointestinal mucosal lesion , prior excision snare .</brief_summary>
	<brief_title>Safety Study SIC 8000 Subjects Undergoing Endoscopic Mucosal Resection ( EMR ) Colonic Lesions Equal Larger Than 2 cm</brief_title>
	<detailed_description>SIC 8000 indicated use gastrointestinal endoscopic procedure submucosal lift polyp , adenomas , early-stage cancer gastrointestinal mucosal lesion , prior excision snare . The current trial focus colonic polyp ≥20 mm remove snare EMR technique . Patients lesion suitable EMR feature strongly suggestive sub-mucosal invasion include .</detailed_description>
	<mesh_term>Adenoma</mesh_term>
	<criteria>1 . Presence treatment naïve , laterally spread sessile , flat polyp adenomas colon equal great 20 mm large dimension , assess investigator suitable EMR . 2 . The base lesion measure least 20mm least one dimension . 3 . A photograph demonstrate lesion size ≥20 mm stiff Boston Scientific Captivator snare 20 mm must record patient prior randomization . 4 . ASA status : limited anesthesiology risk , ASA score 1 , 2 3 . 5 . Contraception : woman childbearing potential must use least one reliable method contraception abstinent . Women nonchildbearing potential postmenopausal status must status least 1 year . For woman childbearing potential , serum pregnancy test result must negative screening . 6 . Full comprehension : ability comprehend full nature purpose study , include possible risk side effect ; ability cooperate investigator comply requirement entire study . 7 . Informed consent : sign write informed consent must complete inclusion study . 1 . Age : Subjects 18 year old exclude 2 . Consent : Subjects refuse unable consent , vulnerable subject exclude . 3 . Pregnancy : Pregnant breastfeed woman 4 . ASA status : High anesthetic risk ( ASA score &gt; 3 ) 5 . Physical finding : clinically significant abnormal physical finding could interfere objective study 6 . Study participation : Subjects currently enrol clinical study previous enrollment clinical study last 30 day 7 . Subjects Lesions le 20 mm large dimension 8 . Subjects Lesions involve muscularis propria ( T2 lesion ) stag modality endoscopic ultrasonography ( EUS ) 9 . Subjects ulcerate depressed lesion ( Paris type III ) biopsy proven invasive carcinoma 10 . Presence malignant disease locally advance metastasis 11 . Presence lesion digestive tract active Inflammatory colonic condition ( inflammatory bowel disease , e.g ulcerative colitis , Crohn 's disease ) 12 . Endoscopic appearance invasive malignancy 13 . Previous treatment lesion ( radiotherapy , endoscopy , surgery , chemotherapy ) exclusionary . Previous cold biopsy target lesion exclusion criterion . 14 . Previous partial resection attempt resection target lesion exclusionary . 15 . Allergy : ascertain presumptive hypersensitivity study product ; history anaphylaxis drug allergic reaction general , investigator considers may affect outcome study . 16. know suspected gastrointestinal obstruction perforation , toxic megacolon , active diverticulitis . 17. inflammatory bowel disease e.g ulcerative colitis Crohn 's 's disease 18 . Hemostasis disorder ( eg Von Willebran disease , haemophilia factor V Leiden thrombophilia ) , know clot disorder ( INR &gt; 1.5 correct ) . 19 . Other medical condition investigator 's opinion would make administration study IMD procedures hazardous subject . 20 . Medical treatment ( i.e . : radiotherapy , surgical endoscopic treatment ) intervention .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>colonic polyp ≥20 mm ,</keyword>
	<keyword>adenoma</keyword>
	<keyword>polyp</keyword>
</DOC>